SFE Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.23M | Sell |
19,432
-75
| -0.4% | -$16.6K | 0.67% | 59 |
|
|
2025
Q4 | $4.46M | Sell |
19,507
-6,522
| -25% | -$1.49M | 0.68% | 57 |
|
|
2025
Q3 | $6.03M | Sell |
26,029
-208
| -0.8% | -$42.4K | 0.96% | 39 |
|
|
2025
Q2 | $4.87M | Buy |
26,237
+4,863
| +23% | +$904K | 0.86% | 44 |
|
|
2025
Q1 | $4.48M | Sell |
21,374
-6,182
| -22% | -$1.2M | 0.89% | 45 |
|
|
2024
Q4 | $4.9M | Sell |
27,556
-3,922
| -12% | -$721K | 1.04% | 36 |
|
|
2024
Q3 | $6.22M | Sell |
31,478
-6
| -0% | -$1.12K | 1.29% | 28 |
|
|
2024
Q2 | $5.4M | Sell |
31,484
-157
| -0.5% | -$26K | 1.2% | 30 |
|
|
2024
Q1 | $5.76M | Sell |
31,641
-628
| -2% | -$108K | 1.31% | 25 |
|
|
2023
Q4 | $5M | Sell |
32,269
-400
| -1% | -$58.3K | 1.3% | 30 |
|
|
2023
Q3 | $4.87M | Sell |
32,669
-319
| -1% | -$46.8K | 1.42% | 25 |
|
|
2023
Q2 | $4.44M | Sell |
32,988
-2,384
| -7% | -$350K | 1.26% | 29 |
|
|
2023
Q1 | $5.36M | Sell |
35,372
-1,211
| -3% | -$185K | 1.66% | 20 |
|
|
2022
Q4 | $5.44M | Sell |
36,583
-1,771
| -5% | -$272K | 1.69% | 18 |
|
|
2022
Q3 | $5.15M | Sell |
38,354
-811
| -2% | -$116K | 1.62% | 18 |
|
|
2022
Q2 | $6M | Sell |
39,165
-1,728
| -4% | -$264K | 1.79% | 17 |
|
|
2022
Q1 | $6.63M | Sell |
40,893
-6,926
| -14% | -$1.01M | 1.68% | 17 |
|
|
2021
Q4 | $6.47M | Sell |
47,819
-29
| -0.1% | -$3.43K | 1.66% | 17 |
|
|
2021
Q3 | $5.16M | Buy |
47,848
+1,575
| +3% | +$180K | 1.45% | 24 |
|
|
2021
Q2 | $5.21M | Buy |
46,273
+1,337
| +3% | +$151K | 1.43% | 27 |
|
|
2021
Q1 | $4.86M | Buy |
44,936
+1,854
| +4% | +$198K | 1.42% | 25 |
|
|
2020
Q4 | $4.62M | Buy |
43,082
+5,669
| +15% | +$545K | 1.47% | 25 |
|
|
2020
Q3 | $3.28M | Buy |
37,413
+5,627
| +18% | +$530K | 1.31% | 26 |
|
|
2020
Q2 | $3.12M | Buy |
31,786
+723
| +2% | +$63.7K | 1.38% | 27 |
|
|
2020
Q1 | $2.37M | Sell |
31,063
-4,235
| -12% | -$361K | 1.3% | 29 |
|
|
2019
Q4 | $3.13M | Sell |
35,298
-1,334
| -4% | -$111K | 1.28% | 29 |
|
|
2019
Q3 | $2.77M | Sell |
36,632
-4,600
| -11% | -$315K | 1.17% | 31 |
|
|
2019
Q2 | $3M | Sell |
41,232
-12,559
| -23% | -$987K | 1.28% | 27 |
|
|
2019
Q1 | $4.33M | Sell |
53,791
-22,229
| -29% | -$1.82M | 1.95% | 18 |
|
|
2018
Q4 | $7.01M | Sell |
76,020
-806
| -1% | -$70.9K | 3.59% | 3 |
|
|
2018
Q3 | $7.27M | Buy |
76,826
+1,466
| +2% | +$139K | 2.8% | 6 |
|
|
2018
Q2 | $6.98M | Buy |
75,360
+5,722
| +8% | +$559K | 2.89% | 4 |
|
|
2018
Q1 | $6.59M | Sell |
69,638
-6,397
| -8% | -$703K | 3.42% | 4 |
|
|
2017
Q4 | $7.35M | Sell |
76,035
-5,131
| -6% | -$484K | 2.97% | 5 |
|
|
2017
Q3 | $7.21M | Sell |
81,166
-11,660
| -13% | -$888K | 3.03% | 3 |
|
|
2017
Q2 | $6.73M | Sell |
92,826
-19,914
| -18% | -$1.34M | 2.73% | 9 |
|
|
2017
Q1 | $7.35M | Sell |
112,740
-806
| -0.7% | -$50.7K | 2.7% | 6 |
|
|
2016
Q4 | $6.88M | Buy |
113,546
+3,646
| +3% | +$223K | 2.65% | 7 |
|
|
2016
Q3 | $6.8M | Hold |
109,900
| – | – | 3.27% | 5 |
|
|
2016
Q2 | $6.8M | Sell |
109,900
-5,515
| -5% | -$336K | 3.17% | 5 |
|
|
2016
Q1 | $6.59M | Sell |
115,415
-805
| -0.7% | -$44.9K | 3.05% | 10 |
|
|
2015
Q4 | $6.88M | Buy |
116,220
+2,004
| +2% | +$115K | 3.27% | 7 |
|
|
2015
Q3 | $6.21M | Sell |
114,216
-4,723
| -4% | -$307K | 2.96% | 8 |
|
|
2015
Q2 | $7.99M | Sell |
118,939
-6,177
| -5% | -$403K | 3.25% | 4 |
|
|
2015
Q1 | $7.32M | Buy |
125,116
+8,231
| +7% | +$497K | 2.96% | 8 |
|
|
2014
Q4 | $7.65M | Sell |
116,885
-5,940
| -5% | -$374K | 3.16% | 6 |
|
|
2014
Q3 | $7.09M | Sell |
122,825
-10,936
| -8% | -$607K | 3.07% | 7 |
|
|
2014
Q2 | $7.55M | Buy |
133,761
+545
| +0.4% | +$28.6K | 3.08% | 7 |
|
|
2014
Q1 | $6.85M | Sell |
133,216
-4,475
| -3% | -$226K | 2.97% | 8 |
|
|
2013
Q4 | $7.27M | Sell |
137,691
-2,760
| -2% | -$136K | 3.16% | 5 |
|
|
2013
Q3 | $6.28M | Buy |
140,451
+4,353
| +3% | +$193K | 3.04% | 6 |
|
|
2013
Q2 | $5.63M | Buy |
+136,098
| New | +$5.95M | 2.9% | 9 |
|
Other funds holding ABBV
VCM
VPM
SFE Investment Counsel's ABBV Position: Q1 2026 in Review
SFE Investment Counsel reduced its AbbVie (ABBV) stake by 0.38% in Q1 2026, selling an estimated $16.6K and leaving 19,432 shares worth $4.23M. The position accounts for 0.67% of the portfolio, ranked #59.
SFE Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.99M in Q2 2015. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- SFE Investment Counsel held 19,432 shares of AbbVie worth $4.23M as of Q1 2026.
- SFE Investment Counsel sold 75 AbbVie shares in Q1 2026, an estimated $16.6K.
- AbbVie made up 0.67% of SFE Investment Counsel's portfolio in Q1 2026, its #59 holding.
- SFE Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- SFE Investment Counsel's AbbVie position peaked at $7.99M in Q2 2015.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on SFE Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.